Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00276159
What this trial is testing

Study of Immune Response Modifier in the Treatment of Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma+3 more
Masonic Cancer Center, University of Minnesota 6
Very early researchStudy completedNCT02405078
What this trial is testing

Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
M.D. Anderson Cancer Center 35
Not applicableUnknownNCT04349540
What this trial is testing

Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19

Who this might be right for
COVID19
Great Ormond Street Hospital for Children NHS Foundation Trust 40
Testing effectiveness (Phase 2)Looking for participantsNCT06238648
What this trial is testing

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedPrimary Mediastinal Large B-Cell LymphomaTransformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Academic and Community Cancer Research United 120
Early research (Phase 1)UnknownNCT03554889
What this trial is testing

Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells

Who this might be right for
Advanced CancerADCCNK Cell Mediated Immunity+2 more
Hangzhou Cancer Hospital 21
Testing effectiveness (Phase 2)Looking for participantsNCT06548789
What this trial is testing

Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 35
Not applicableStudy completedNCT02854644
What this trial is testing

Study of the Anti-tumoral Immune Response

Who this might be right for
Breast CancerGlioma
Centre Hospitalier Universitaire de Besancon 167
Early research (Phase 1)Study completedNCT00083330
What this trial is testing

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

Who this might be right for
HealthyHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableLooking for participantsNCT05290363
What this trial is testing

The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis

Who this might be right for
Spondyloarthritis
Institut Pasteur 90
Testing effectiveness (Phase 2)Study completedNCT00565981
What this trial is testing

A Pilot Trial With Subcutaneous Alemtuzumab and Oral Fludarabinephosphate for the Determination of Safety, Efficacy and Molecular Profiling for the Prediction of Response

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
Arbeitsgemeinschaft medikamentoese Tumortherapie 10
Not applicableUnknownNCT04568044
What this trial is testing

Evaluation of Humoral Immunity Following COVID-19 in Pregnancy

Who this might be right for
COVID-19Pregnancy RelatedInfluenza, Human
Imperial College London 128
Not applicableNot Yet RecruitingNCT07698093
What this trial is testing

Monitoring of Septic Shock-induced Immunosuppression

Who this might be right for
Sepsis
Hospices Civils de Lyon 300
Early research (Phase 1)Not Yet RecruitingNCT07720843
What this trial is testing

TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Montefiore Medical Center 50
Early research (Phase 1)Study completedNCT00680589
What this trial is testing

Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00698490
What this trial is testing

Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines

Who this might be right for
Prophylaxis Herpes Simplex
GlaxoSmithKline 130
Post-approval studies (Phase 4)UnknownNCT05133310
What this trial is testing

Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

Who this might be right for
StrainsAcute Lymphoblastic LeukemiaSepsis
Hospital General de Mexico 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT02858921
What this trial is testing

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma

Who this might be right for
Melanoma
Melanoma Institute Australia 60
Not applicableUnknownNCT00368615
What this trial is testing

Characterization of the Melanoma-Specific Immune Response

Who this might be right for
Melanoma
University of California, Davis 20
Not applicableUnknownNCT01198808
What this trial is testing

Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker

Who this might be right for
Bladder Cancer
Technical University of Munich 50
Testing effectiveness (Phase 2)Study completedNCT02000817
What this trial is testing

Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients

Who this might be right for
Diabetes Mellitus, Type 1
GlaxoSmithKline 30
Next Page